Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. ((4ar)-1-(4-fluorophenyl)-6-((1-methyl-1h-pyrazol-4-yl)sulfonyl)-1,4,5,6,7,8-hexahydro-4ah-pyrazolo(3,4-g)isoquinolin-4a-yl)(4-(trifluoromethyl)-2-pyridinyl)methanone
2. Cort125134
3. Methanone, ((4ar)-1-(4-fluorophenyl)-1,4,5,6,7,8-hexahydro-6-((1-methyl-1h-pyrazol-4-yl)sulfonyl)-4ah-pyrazolo(3,4-g)isoquinolin-4a-yl)(4-(trifluoromethyl)-2-pyridinyl)-
1. 1496510-51-0
2. Cort125134
3. Cort-125134
4. Relacorilant [inn]
5. Relacorilant [who-dd]
6. Cort 125134
7. Chembl4068611
8. Relacorilant (usan)
9. 2158753c7e
10. Relacorilant [usan]
11. [(4ar)-1-(4-fluorophenyl)-6-(1-methylpyrazol-4-yl)sulfonyl-4,5,7,8-tetrahydropyrazolo[3,4-g]isoquinolin-4a-yl]-[4-(trifluoromethyl)pyridin-2-yl]methanone
12. Methanone, [(4ar)-1-(4-fluorophenyl)-1,4,5,6,7,8-hexahydro-6-[(1-methyl-1h-pyrazol-4-yl)sulfonyl]-4ah-pyrazolo[3,4-g]isoquinolin-4a-yl][4-(trifluoromethyl)-2-pyridinyl]-
13. ((4ar)-1-(4-fluorophenyl)-6-(1-methyl-1h-pyrazole-4-sulfonyl)-1,4,5,6,7,8-hexahydro-4ah-pyrazolo(3,4-g)isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone
14. Methanone, ((4ar)-1-(4-fluorophenyl)-1,4,5,6,7,8-hexahydro-6-((1-methyl-1h-pyrazol-4-yl)sulfonyl)-4ah-pyrazolo(3,4-g)isoquinolin-4a-yl)(4-(trifluoromethyl)-2-pyridinyl)-
15. (r)-(1-(4-fluorophenyl)-6-((1-methyl-1h-pyrazol-4-yl)sulfonyl)-1,4,5,6,7,8-hexahydro-4ah-pyrazolo(3,4-g)isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone
16. (r)-(1-(4-fluorophenyl)-6-((1-methyl-1h-pyrazol-4-yl)sulfonyl)-1,4,5,6,7,8-hexahydro-4ah-pyrazolo[3,4-g]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone
17. Relacorilant [usan:inn]
18. Schembl15454999
19. Dtxsid801099345
20. Unii-2158753c7e
21. Ex-a4253
22. Bdbm50265673
23. Nsc812727
24. Zinc141949519
25. Db14976
26. Nsc-812727
27. Ac-36530
28. Cort 125134cort 125134
29. Hy-109042
30. Cs-0031484
31. J3.651.009i
32. D11336
33. F78015
34. A936317
35. ((4ar)-1-(4-fluorophenyl)-6-((1-methyl-1h-pyrazol-4-yl)sulfonyl)-1,4,5,6,7,8-hexahydro-4ah-pyrazolo(3,4-g)isoquinolin-4a-yl)(4-(trifluoromethyl)-2-pyridinyl)methanone
36. (r)-(1-(4-fluorophenyl)-6-((1-methyl-1h-pyrazol-4-yl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1h-pyrazolo[3,4-g]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone
| Molecular Weight | 586.6 g/mol |
|---|---|
| Molecular Formula | C27H22F4N6O3S |
| XLogP3 | 2.9 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 5 |
| Exact Mass | 586.14102241 g/mol |
| Monoisotopic Mass | 586.14102241 g/mol |
| Topological Polar Surface Area | 111 Ų |
| Heavy Atom Count | 41 |
| Formal Charge | 0 |
| Complexity | 1140 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Relacorilant manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Relacorilant, including repackagers and relabelers. The FDA regulates Relacorilant manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Relacorilant API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Relacorilant supplier is an individual or a company that provides Relacorilant active pharmaceutical ingredient (API) or Relacorilant finished formulations upon request. The Relacorilant suppliers may include Relacorilant API manufacturers, exporters, distributors and traders.
Relacorilant Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Relacorilant GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Relacorilant GMP manufacturer or Relacorilant GMP API supplier for your needs.
A Relacorilant CoA (Certificate of Analysis) is a formal document that attests to Relacorilant's compliance with Relacorilant specifications and serves as a tool for batch-level quality control.
Relacorilant CoA mostly includes findings from lab analyses of a specific batch. For each Relacorilant CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Relacorilant may be tested according to a variety of international standards, such as European Pharmacopoeia (Relacorilant EP), Relacorilant JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Relacorilant USP).
LOOKING FOR A SUPPLIER?
